GLP-1-based therapy was developed in the 1990s and treatment with daily injectable GLP-1 receptor agonists and oral dipeptidyl peptidase-4 (DPP-4) inhibitors was introduced in the 2000s [2]
Beyond membrane-bound receptors, melatonin also interacts with intracellular proteins such as calmodulin and nuclear receptors, extending its biological activity [29, 30]
By the 1970s, furosemide became one of the most commonly prescribed diuretics, with fewer undesired effects compared to earlier diuretics, including hydrochlorothiazide (Feit, 1971
The body uses methyl B12 as a co-factor to convert homocysteine back into methionine
Unlike traditional treatments, BPC-157 promotes tissue repair, enhances tendon and ligament healing, and may reduce the need for invasive procedures or long-term medication use
The underlying pathologies differ